Global Polymerase Chain Reaction Market to Amount to USD 27.4 Billion by 2015, Projects Axis Research Mind14 Jun 2013 • by Natalie Aster
The global PCR market is projected to reach around US$27.4 billion by 2015, with a Compounded Annual Growth Rate (CAGR) of 13.9% for the analysis period, 2009-2015. North America is estimated as the largest market with a market share of 40% of global market and projects US$10.7 billion by end-2010. Europe and Asia-Pacific together account for more than 50% of the global market share. Interestingly, Latin America is seen as the fastest growing market with a CAGR of 14.8%, to worth around US$1.3 billion in 2015.
Among the techniques used, Q-PCR appears to be the fastest growing market with a CAGR of 14.9%. Reverse-Transcription PCR (RT-PCR) and Assembly PCR are expected grow with a CAGR of 14.3% and 14% respectively.
Based on the classification by products/tools, PCR Reagents are expected to be fastest growing market with a CAGR of 14.6%. PCR Consumables and PCR Machines are expected grow with a CAGR of 14.2% and 13.1% respectively.
Global PCR Research market forecasts a CAGR of 13.3% during the analysis period 2009-2015. PCR Diagnosis market is expected to represent the market share of 29.9% by 2015. PCR Infectious Diseases stand as the fastest growing market.
The report “Polymerase Chain Reaction (PCR) In Medical Application - An Analytical Report, 2009-2015” by Axis Research Mind reviews the latest PCR market trends with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for life science sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs) and many more in preferred locations.
Polymerase Chain Reaction (PCR) In Medical Application - An Analytical Report, 2009-2015
Published: June, 2013
Price: US$ 4,600.00
The period considered for the PCR market analysis is 2009-2015. The region wise distribution of the market consists of North America (USA and Canada), Europe (France, Germany, United Kingdom, Italy, Spain and Rest of Europe), Asia- Pacific (Japan, China, India, Korea and Rest of Asia-Pacific), Latin America (Brazil, Columbia, Argentina and Rest of Latin America) and Rest of the World. Incorporating the recession impacts on the industry, the market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually for the upcoming years.
More than 850 leading market players are identified and 49 key companies that project improved market activities in the near future are profiled. The report consists of 379 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.
The broad ‘life science’ division has been witnessing a rapid growth and technological improvements varying from sector to sector since the past 3-5 years. Accelerating growth rate exhibited by the PCR industry, even during the recession years, confirms the positive growth prospects going ahead. Among the major developments in the recent years, gene amplification technology indicates the highest potential growth. Molecular diagnostics and the Human Genome Project (HGP) are two of the main drivers that contribute to the growth of gene amplification technology. It covers all segments such as drug discovery, DNA amplification, forensic identification, gene therapy and diagnosis. Freshly developed PCR Instruments for detecting most of the life threatening diseases also signal positive demand growth. Among the PCR types, q-PCR is expected witness the largest CAGR during 2009-2015.
Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates. Estimates have incorporated recessionary impact on the PCR industry.
More information can be found in the report “Polymerase Chain Reaction (PCR) In Medical Application - An Analytical Report, 2009-2015” by Axis Research Mind.
To order the report or ask for sample pages contact firstname.lastname@example.org